SCHEMBL3783705

SCHEMBL3783705

CNc1cccc(B(O)O)c1NC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
POLB P06746 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 2/20 0.35
RECQL P46063 2/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ENPP2 Q13822 2/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
EGFR P00533 1/20 0.33
PABPC1 P11940 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
IDO1 P14902 1/20 0.32
PDK2 Q15119 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469192 0.79 POLB (0.44) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL3198768 0.79 POLB (0.44) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL27663842 0.78 POLB (0.46) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL3790482 0.77 KDM4E (0.34) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL3788553 0.77 CYP3A4 (0.36) MAPTKDM4ETDP1ALDH1A1HPGD
SCHEMBL3791237 0.75 MAPT (0.39) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL1952571 0.73 IDO1 (0.43) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL18754380 0.72 ENPP2 (0.31) ENPP2
SCHEMBL4648220 0.70 RAPGEF4 (0.41) MAPTKDM4EPOLBTDP1L3MBTL1
SCHEMBL3786919 0.69 CYP3A4 (0.39) MAPTKDM4EPOLBALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885KDM4E 2606/4885POLB 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.